pes-10 Antibody
Product Specs
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Target Background
Q&A
Basic Research Questions
How do I validate PES1 antibody specificity in western blotting for cancer cell studies?
-
Perform parallel experiments with positive/negative controls (e.g., PES1-overexpressing vs. knockout cell lines).
-
Validate using siRNA-mediated PES1 knockdown: a 72 kDa band should diminish upon knockdown .
-
Confirm cross-reactivity with species homologs (e.g., mouse, goat) via comparative blotting .
What experimental designs optimize PES1 detection in immunofluorescence (IF)?
-
Use antigen retrieval with TE buffer (pH 9.0) for formalin-fixed tissues .
-
Combine IF with lysosomal markers (e.g., LAMP1) to study PES1’s role in lysosome-mediated pathways .
-
Include pepstatin A (a cathepsin D inhibitor) to validate lysosomal permeabilization artifacts .
How to resolve discrepancies in PES1 antibody reactivity across cell types?
-
Assess HSP70 expression levels, as PES1 activity may correlate with stress-response pathways .
-
Optimize antibody dilution gradients (1:50–1:500 for IF/IHC) to account for epitope accessibility differences .
Advanced Research Questions
How can PES1 inhibition be combined with proteasome inhibitors for enhanced lymphoma cytotoxicity?
-
Co-treat with bortezomib (10 nM) and PES (10–20 μM) to exploit HSP70 upregulation post-proteasome inhibition .
-
Monitor mitochondrial depolarization via JC-1 staining and Bid cleavage via western blot .
Key Data Table: PES1 Antibody Performance
What methodologies address PES1’s role in immunogenic cell death?
-
Coculture PES-treated lymphoma cells (e.g., BC3) with dendritic cells (DCs) to assess CD86 upregulation via FACS .
-
Use Annexin-V/PI staining to differentiate apoptosis from caspase-independent death .
How to troubleshoot nonspecific binding in PES1 immunoprecipitation (IP)?
-
Preclear lysates with protein A/G beads and optimize IP antibody concentration (0.5–4.0 μg per 1–3 mg lysate) .
-
Validate using mass spectrometry to confirm co-precipitated partners (e.g., BRCT domain interactors) .
Methodological Considerations
-
Data Contradiction Analysis: If PES1 inhibition shows variable cytotoxicity, correlate results with HSP70 expression levels (higher in cancer vs. normal B cells) .
-
Neutralization Assays: For spike protein studies, compare phage-displayed scFvs (e.g., SLISY) with full-length antibodies to exclude steric interference .
